$FOLD AMICUS THERAPEUTICS, INC. Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AMICUS THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in AMICUS THERAPEUTICS, INC.. Find out how many shares they currently own, their value and whether they buy or sell their shares.
AMICUS THERAPEUTICS, INC. Insiders
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| Andrews Kurt J. | SVP, Human Resources | 40,469 | 243,623 | Jul 05 2018 | |||
| Baird William D III | Chief Financial Officer | 127,622 | 768,284 | Oct 17 2018 | |||
| Baldry Mark | VP Global Marketing | 25,000 | 150,500 | Jun 04 2015 | |||
| BARER SOL J | Director | 0 | 0 | Jun 13 2016 | |||
| BARER SOL J | Director | 45,000 | 270,900 | Jun 16 2014 | |||
| BARER SOL J | Director | 20,000 | 120,400 | Jun 14 2011 | |||
| BARKAS ALEXANDER E | Director | 33,608 | 202,320 | Jun 14 2011 | |||
| BARRETT M JAMES | Director | 4,584,311 | 27,597,552 | Jun 16 2014 | |||
| BARRIS PETER J | 10% Owner | 851,183 | 5,124,122 | Jul 27 2007 | |||
| BARRIS PETER J | 10% Owner | 4,584,311 | 27,597,552 | Mar 09 2012 | |||
| Barth Jay | Chief Medical Officer | 191,954 | 1,155,563 | Sep 02 2020 | |||
| Bleil Lynn Dorsey | Director | 21,705 | 130,664 | Jun 08 2020 | |||
| Bloch Stephen M | Director | 61,700 | 371,434 | Feb 12 2009 | |||
| Bloch Stephen M | Director | 68,804 | 414,200 | Aug 19 2008 | |||
| Bloch Stephen M | Director | 66,936 | 402,955 | Sep 11 2008 | |||
| Boudes Pol F | Chief Medical Officer | 0 | 0 | Feb 17 2012 | |||
| Boudes Pol F | Chief Medical Officer | 0 | 0 | Jun 06 2012 | |||
| Campbell Bradley L | Chief Operating Officer | 436,397 | 2,627,110 | Jun 09 2021 | |||
| Campbell Bradley L | Chief Operating Officer | 200,000 | 1,204,000 | Jan 30 2015 | |||
| Canaan Equity Partners III LLC | 10% Owner | 2,050,790 | 12,345,756 | Jun 07 2007 | |||
| Castelli Jeff | SVP, Program Management | 25,000 | 150,500 | Jun 24 2015 | |||
| CHL Medical Partners II, L.P. | 10% Owner | 2,108,554 | 12,693,495 | Jun 07 2007 | |||
| CHL Medical Partners II Side Fund, L.P. | 10% Owner | 2,108,555 | 12,693,501 | Jun 07 2007 | |||
| Clark David Michael | Chief People Officer | 174,389 | 1,049,822 | Apr 08 2021 | |||
| Crowley John F | Chairman & CEO | 905,287 | 5,449,828 | Jun 09 2021 | |||
| Crowley John F | Chairman & CEO | 109,083 | 656,680 | Jan 30 2015 | |||
| David Allsop | SVP International | 50,000 | 301,000 | Apr 28 2015 | |||
| Dentzer James E | Chief Financial Officer | 32,075 | 193,092 | Oct 01 2009 | |||
| Dentzer James E | Chief Financial Officer | 35,375 | 212,958 | Jul 02 2008 | |||
| Dilone Enrique | SVP, Technical Operations | 30,688 | 184,742 | Jun 23 2015 | |||
| Dilone Enrique | VP, Technical Operations | 50,000 | 301,000 | Jan 30 2015 | |||
| Do Hung | Chief Science Officer | 448,617 | 2,700,674 | Apr 08 2021 | |||
| Doshi Dipal | SVP Strategy & Bus Dev | 1,706 | 10,270 | Jul 09 2015 | |||
| ESSNER ROBERT | Director | 21,000 | 126,420 | Jun 08 2020 | |||
| ESSNER ROBERT | Director | 0 | 0 | Jun 16 2014 | |||
| FHM IV LP | 10% Owner | 497,890 | 2,997,298 | Feb 06 2008 | |||
| FHM IV LP | 10% Owner | 920,664 | 5,542,397 | Mar 10 2008 | |||
| Garden State Life Sciences Venture Fund L P | 10% Owner | 1,419,762 | 8,546,967 | Jun 07 2007 | |||
| Gershkowitz Jayne | SVP, Chief Patient Advocate | 5,693 | 34,272 | Jul 01 2015 | |||
| Gilmore Geoffrey | SVP & General Counsel | 0 | 0 | Mar 13 2012 | |||
| GLAXOSMITHKLINE PLC | 10% Owner | 11,315,825 | 68,121,267 | Nov 22 2013 | |||
| GLAXOSMITHKLINE PLC | 10% Owner | 0 | 0 | Oct 28 2014 | |||
| HAYDEN DONALD J JR | Director | 8,895 | 53,548 | Jun 11 2018 | |||
| HAYDEN DONALD J JR | Director | 0 | 0 | Jun 20 2011 | |||
| HAYDEN DONALD J JR | Director | 0 | 0 | Jun 16 2014 | |||
| John McAdam M | VP, Finance & Accounting | 0 | 0 | Jun 17 2010 | |||
| Kelly Michael Aaron | Director | 8,837 | 53,199 | Dec 02 2020 | |||
| Kirk John | VP, Regulatory Affairs | 5,687 | 34,236 | Jun 03 2015 | |||
| Kirk John | VP, Regulatory Affairs | 50,000 | 301,000 | Jan 30 2015 | |||
| KRAMLICH C RICHARD | 10% Owner | 851,183 | 5,124,122 | Jul 27 2007 | |||
| KRAMLICH C RICHARD | 10% Owner | 4,584,311 | 27,597,552 | Mar 09 2012 | |||
| Licholai Gregory P | VP, Medical Affairs | 152 | 915 | Feb 05 2009 | |||
| Lockhart David J | Chief Scientific Officer | 0 | 0 | Feb 17 2012 | |||
| Lockhart David J | Chief Scientific Officer | 0 | 0 | Jun 20 2013 | |||
| LOVE TED W | Director | 131,000 | 788,620 | Jun 08 2020 | |||
| LOVE TED W | Director | 142,000 | 854,840 | Dec 15 2014 | |||
| Macaluso Peter M | VP & Corporate Counsel | 0 | 0 | Jun 20 2013 | |||
| MCGLYNN MARGARET G | Director | 37,919 | 228,272 | May 05 2021 | |||
| MCGLYNN MARGARET G | Director | 0 | 0 | Jun 14 2011 | |||
| MCGLYNN MARGARET G | Director | 0 | 0 | Jun 16 2014 | |||
| NEFF P SHERRILL | Director | 1,419,762 | 8,546,967 | Jun 17 2010 | |||
| NEFF P SHERRILL | Director | 0 | 0 | Jun 13 2008 | |||
| NEW ENTERPRISE ASSOCIATES 11 LP | 10% Owner | 4,584,311 | 27,597,552 | Mar 09 2012 | |||
| NEWHALL CHARLES W III | 10% Owner | 851,183 | 5,124,122 | Jul 27 2007 | |||
| NEWHALL CHARLES W III | 10% Owner | 4,584,311 | 27,597,552 | Mar 09 2012 | |||
| Palling David | Sr VP, Technical Operations | 34,040 | 204,921 | Jun 30 2009 | |||
| Patterson Matthew R | Acting CEO & President | 106,547 | 641,413 | Apr 19 2011 | |||
| Peist Kenneth | VP, Legal & IP | 18,874 | 113,621 | Jan 06 2016 | |||
| Peist Kenneth | VP, Legal & IP | 50,000 | 301,000 | Jan 30 2015 | |||
| PERCEPTIVE ADVISORS LLC | 10% Owner | 20,694,424 | 124,580,432 | Oct 05 2018 | |||
| PERCEPTIVE ADVISORS LLC | 10% Owner | 14,439,444 | 86,925,453 | Nov 19 2014 | |||
| PERRY MARK W | 10% Owner | 851,183 | 5,124,122 | Jul 27 2007 | |||
| PERRY MARK W | 10% Owner | 4,584,311 | 27,597,552 | Mar 09 2012 | |||
| PROSPECT VENTURE PARTNERS II LP | 10% Owner | 33,608 | 202,320 | Jun 06 2007 | |||
| Prout Samantha Whiteman | Principal Accounting Officer | 88,875 | 535,028 | Apr 19 2021 | |||
| QUAKER BIO VENTURES LP | 10% Owner | 1,419,762 | 8,546,967 | Jun 07 2007 | |||
| Quimi Daphne | Chief Financial Officer | 290,629 | 1,749,587 | Apr 08 2021 | |||
| Quimi Daphne | VP Finance and Controller | 50,000 | 301,000 | Jan 30 2015 | |||
| RAAB MICHAEL | Director | 21,000 | 126,420 | Jun 08 2020 | |||
| RAAB MICHAEL | Director | 0 | 0 | Jun 11 2008 | |||
| RAAB MICHAEL | Director | 0 | 0 | Jun 14 2011 | |||
| RAAB MICHAEL | Director | 0 | 0 | Jun 16 2014 | |||
| Redmile Group, LLC | 10% Owner | 12,956,446 | 77,997,805 | Jun 13 2016 | |||
| Rosenberg Ellen | Chief Legal Officer | 241,206 | 1,452,060 | Apr 08 2021 | |||
| SBLENDORIO GLENN | Director | 33,933 | 204,277 | Jun 08 2020 | |||
| SBLENDORIO GLENN | Director | 12,933 | 77,857 | Jun 14 2011 | |||
| SBLENDORIO GLENN | Director | 11,933 | 71,837 | Aug 29 2014 | |||
| Schaeffer Orlov S Nicole | SVP, HR & Leadership Devt | 12,582 | 75,744 | Feb 17 2012 | |||
| Shenker Andrew | VP, Clinical Research | 0 | 0 | Feb 05 2009 | |||
| Topper James N | Director | 13,128 | 79,031 | Jun 14 2011 | |||
| Topper James N | Director | 920,664 | 5,542,397 | Mar 10 2008 | |||
| Topper James N | Director | 149,134 | 897,787 | Jun 29 2007 | |||
| Topper James N | Director | 0 | 0 | Jun 12 2008 | |||
| Topper James N | Director | 0 | 0 | Jun 16 2014 | |||
| Valenzano Ken | SVP, Pharmacology & Biology | 27,687 | 166,676 | Jul 15 2015 | |||
| Valenzano Ken | VP, Pharmacology & Biology | 50,000 | 301,000 | Jan 30 2015 | |||
| Weinhoff Gregory M | Director | 2,108,555 | 12,693,501 | Jun 07 2007 | |||
| Weinhoff Gregory M | Director | 129,943 | 782,257 | Aug 18 2008 | |||
| WHEELER CRAIG A | Director | 31,115 | 187,312 | Jun 14 2021 | |||
| WHITMAN BURKE W | Director | 47,467 | 285,751 | Jun 02 2021 | |||
| Winkler Robert E | VP, Clin Research & Operations | 0 | 0 | Feb 17 2012 | |||
| Winkler Robert E | VP, Clin Research & Operations | 0 | 0 | Jun 06 2012 | |||
| Winterbottom Joan | SVP, Human Resources | 1,665 | 10,023 | Jun 20 2013 | |||
| Yu Julie | VP Clinical Ops & Data Mgmt | 0 | 0 | Jun 16 2015 |